Hangzhou Gaoguang Pharmaceutical

Hangzhou Gaoguang Pharmaceutical

Small molecule drugs for treatment of autoimmune diseases and cancer.

HQ location
Hangzhou, China
Launch date
Enterprise value
$83—124m
  • Edit
More about Hangzhou Gaoguang Pharmaceutical
Made with AI
Edit

Highlightll Pharmaceutical USA LLC is dedicated to discovering breakthrough medicines with significant impacts on healthcare. The company operates globally, not confined to a single region or therapeutic area, and combines worldwide resources and expertise with its unique perspectives to address challenging medical problems. Highlightll differentiates itself by seeking competitive advantages in all its projects. Its lead program features the world's first highly potent and selective dual TYK2 JAK1 inhibitor, showcasing its commitment to high-impact solutions. The business primarily serves the healthcare sector, focusing on developing advanced pharmaceutical solutions. Revenue is generated through the development and commercialization of these innovative medicines.

Keywords: pharmaceuticals, healthcare, global, breakthrough, medicines, TYK2, JAK1, inhibitor, expertise, competitive

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads